Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Neusoft Xikang Partners with Dr. Mehmet Oz for Collaborative Innovations to Build Global Health Community


News provided by

Neusoft Corporation

07 Jun, 2013, 07:39 GMT

Share this article

Share toX

Share this article

Share toX

SHENYANG, China, June 7, 2013 /PRNewswire/ -- Neusoft Corporation ("Neusoft", SSE: 600718), a leading IT solution and service provider in China, recently announced that its subsidiary, Neusoft Xikang Healthcare Technology Co., Ltd. ("Neusoft Xikang"), partnered with Oz Media, Dr. Mehmet Oz's holding company for collaborative innovations, to build a cross-national health community. As Vice-Chair and Professor of Surgery at New York Presbyterian/ Columbia University and the host of The Dr. Oz Show, Dr. Oz will bring his extensive resources of health management methods, knowledge, books and videos into Neusoft Xikang platform and this partnership will significantly drive the development of health management theories and methodologies in China to reach the international level, and promote the exchanges and cooperation between China and the United States in the field of health management, chronic disease prevention and health education.

Continue Reading
This image opens in the lightbox

Dr. Oz, is a renowned expert in the field of heart surgery in the United States. He has been focusing on the research and practice of cardiovascular disease and health management. In addition, he has been actively promoting uplifting health insights through books, articles, radio, and TV programs, which made him an influential thought leader on healthcare in the United States and throughout the world. He is the two-time Daytime Emmy® Award-winning host of the two-time Daytime Emmy® Award-winningThe Dr. Oz Show, which is broadcast in 118 countries and highly favored by millions of audiences worldwide. He has authored over 400 original publications, book chapters, and medical textbooks, as well as 7 New York Times best-selling books from the "YOU: the Owner's Manual" series.

According to the partnership, Dr. Oz will serve as Neusoft Xikang's Chief Healthcare Advisor, contributing to the company's strategy and business development planning. He will provide professional healthcare knowledge and methods to China market through Neusoft Xikang's channels and resources, and Neusoft Xikang will integrate Dr. Oz's advanced healthcare methods and practices, especially in health education and communication, with its Xikang Cloud Platform, to accelerate the development of health management in China and create an O2O model global health community that can provide consumers with real time personal health data analysis, assessment, and advanced health management solutions.  

"We cannot have a wealthy society without being a healthy society, yet many people do not know how to take good care of their own bodies, how to change bad habits, and how to live a longer and healthier life," Dr. Oz said, "People throughout the world face increasingly similar health challenges caused by our modern lifestyle. I have had a long interest in China's traditional medicine, which contains many profound theories on chronic diseases and enlightments for healthier living. I'm very pleased to visit China and join hands with Neusoft Xikang to integrate American health management practice with Chinese medical practices and innovative healthcare technology. I believe this partnership will spur new dynamism for the existing healthcare ecosystem, and significantly promote the development of novel health management approaches in China. Using our TV shows, books and many other media assets, we want to celebrate people as they enjoy the benefits of healthier lives. Sharing this wisdom with the Chinese public will bring joy to our new audience and our team. We believe that the Xikang team offers a novel vision for the future of healthcare and we are honored to be included on this voyage."

Dr. Liu Jiren, Chairman & CEO of Neusoft Corporation, said, "Dr. Oz is a professional, wise healthcare expert and an energic, influential thought leader in this area. He is very good at communicating advanced and complex healthcare science and methodologies in an easy-to-understand, humorous manner. This partnership between Dr. Oz and Neusoft marks a perfect combination of leading health management methodologies and innovative technology platform, which will also enhance the exchanges between developed countries and emerging countries in the field of health management. Looking into the future, we will join efforts to create a global health community to provide comprehensive health services for Chinese people and promote collaborative innovations in the global healthcare industry."

About Dr. Mehmet Oz

Dr. Oz, two-time Daytime Emmy® Award-winning host of the two-time Daytime Emmy® Award-winning The Dr. Oz Show, is Vice-Chair and Professor of Surgery at Columbia University. He directs the Cardiovascular Institute and Complementary Medicine Program at New York Presbyterian Hospital. His research interests include heart replacement surgery, minimally invasive cardiac surgery, complementary medicine and healthcare policy. He has received several patents, and performs more than 100 heart surgeries per year. He has been a regular columnist in O, the Oprah Magazine, Time, Goodhousekeeping and Esquire.

Remarkably, Dr. Oz was named Forbes' #3 most influential celebrity (2010-2011), has been honored as one of Time magazine's 100 Most Influential People (2008), Esquire magazine's 75 Most Influential People of the 21st Century, and a Global Leader of Tomorrow by the World Economic Forum (1999-2004). He has also won the prestigious Gross Surgical Research Scholarship, received an honorary doctorate from Istanbul University and was voted a "Doctor of the Year" by Hippocrates magazine.

(Photo: http://photos.prnewswire.com/prnh/20130607/CN28178)

About Neusoft Xikang Healthcare Technology Co., Ltd.

Neusoft Xikang Healthcare Technology Co., Ltd.is a subsidiary of Neusoft Corporation mainly engaged in technology development, transfer, consulting and service for computer hardware and electronic products.

Xikang, as a landmark brand for Neusoft in health management area, provides individuals and families with full-life-cycle healthcare platform by integrating health Internet of Things and health cloud platforms with premium medical resources as well as regional medical centers and community medical institutions. The Xikang healthcare platform is innovatively equipped with all-in-one health data monitoring equipment to provide affordable, efficient and convenient healthcare service for individuals and families. Besides, the platform is missioned to become a leading online healthcare platform for hospitals and public health administrative authorities to promote the on-going healthcare reform of China.

For more information, please contact:

     Evelyn Tang
     Branding & Marketing Management Center
     Neusoft Corporation
     Phone: +86-24-8366-5663
     Email: tangyi@neusoft.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.